abstract |
FIELD: biotechnology. n SUBSTANCE: invention relates to a compound of formula 1 n n n n that is a new rebamipide prodrug, and to the pharmaceutical composition thereof. n EFFECT: new rebamipide prodrug with absorption rate 25 times higher than that of rebamipide, which can be used for prevention or treatment of gastric ulcer, acute gastritis, chronic gastritis, xerophthalmia, cancer, osteoarthritis, rheumatoid arthritis, or obesity. n 7 cl, 3 tbl, 204 ex, 1 dwg |